LIC Q4 Results 2022

India’s largest insurance company, LIC (Life Insurance Corporation of India) declared its Q4 results on Monday. 

LIC’s net profit fell 18% to Rs 2,372 crore for the fourth quarter ended 31 March 2022. The insurance company published a profit of Rs 2,893 crore last year. 

The insurance giant’s net premium income rose to Rs 1.44 lakh crore, up 18% for the quarter from Rs 1.22 lakh crore (in the same quarter) last year. 

The Board of Directors has proposed a dividend of Rs 1.50 per equity share.

For the newly listed company, this is the first quarter financial results declaration.

More on LIC’s Q4

LIC had earlier announced a behemoth Rs. 21,000 crore initial public offering (IPO) on May 4, with a price band between Rs. 902- Rs. 949 per equity share. LIC listing was a government disinvestment exercise, wherein the GOI sold over 22.13 crore shares or a 3.5% stake

The IPO, much to its fan-fare raised $2.7 billion, with buyers, ranging from sovereign funds in Norway and Singapore, to millions of Indian retail investors. However, it had a tepid listing on the indices and is trading nearly 15% below the cutoff price (since its listing on May 17).

On Monday, LIC's script traded 1.89% higher at Rs 837.05 apiece. 

Highlights of LIC Q4 Results 2022

• LIC’s net premium income stood at Rs 1.44 lakh crore, up 18% from Rs.1.2 lakh crores on a yearly based. 
• The company declared a dividend of Rs.1.5 per equity share
• LIC shares traded nearly 2% high on account of results today

Misses of LIC Quarterly Results

• LIC reported a dip in profits to Rs. 2,372 crores, down 18% Y-o-Y
• The script has been trading at a discount of 15% since listing

In other news

• LIC’s market capitalization stood at an impressive Rs. 5,29,466 crores 
• Its P/E ratio trailed at 183
• LIC’s ROCE and ROE came in at 310% and 81.7% 
• The insurance giant has more than 65% of the market share
• LIC offers participating insurance products and other products like ULIP, saving insurance products, term insurance, health insurance, annuity and pension

To read the RA disclaimer, please click here
Research Analyst: Bavadharini KS